Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: An exploratory study

Cancer Causes and Control

Volumn 23, Issue 7, 2012, Pages 1065-1074

  Kotsopoulos, Joanne ^a   Sukiennicki, Grzegorz ^b   Muszyńska, Magdalena ^b   Gackowski, Daniel ^c   Kąklewski, Krzysztof ^b   Durda, Katarzyna ^b   Jaworska, Katarzyna ^b   Huzarski, Tomasz ^b   Gronwald, Jacek ^b   Byrski, Tomasz ^b   Ashuryk, Oleg ^b   Dębniak, Tadeusz ^b   Tołoczko Grabarek, Aleksandra ^b   Stawicka, Małgorzata ^d   Godlewski, Dariusz ^d   Oliński, Ryszard ^c   Jakubowska, Anna ^b   Narod, Steven A ^a   Lubinski, Jan ^b  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d Prophylactics and Epidemiology Centre   (Poland)

Author keywords

BRCA1; Breast cancer; Iron; Micronutrients; Retinol

Indexed keywords

ANTIMONY; IRON; RETINOL; TRACE ELEMENT;

ADULT; AGED; ANTIMONY BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EXPLORATORY RESEARCH; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IRON BLOOD LEVEL; ONCOGENE; POLAND; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TRACE ELEMENT BLOOD LEVEL;

EID: 84862493021     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9975-0     Document Type: Article

References (76)

1. Ford D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676-689 (Pubitemid 28164626)
2. Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130 (Pubitemid 36530000)
3. Narod S et al (1993) Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet 341(8852):1101-1102 (Pubitemid 23114447)
4. Foulkes WD et al (2002) Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study. J Med Genet 39(6):407-409 (Pubitemid 34664974)
5. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646 (Pubitemid 37310920)
6. Nkondjock A et al (2006) Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 118(1):103-107 (Pubitemid 41681585)
7. Kowalska E et al (2005) Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev 14(5):1302-1306 (Pubitemid 40656485)
8. Kotsopoulos J et al (2010) Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers. Cancer Causes Control 21(5):679-687
9. Kotsopoulos J et al (2005) Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 7(5):R833-R843
10. Kotsopoulos J, Narod SA (2005) Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control 16(2):125-138 (Pubitemid 40691208)
11. Scott R (2004) DNA double strand break repair and its association with inherited predispositions to breast cancer. Hereditary Cancer in Clinical Practice 2(1):37-43
12. Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25(43):5832-5836
13. Lubinski J et al. (2012) The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer 131(1):229-234
14. Siomek A et al (2007) Higher leukocyte 8-oxo-7,8-dihydro-2′- deoxyguanosine and lower plasma ascorbate in aging humans? Antioxid Redox Signal 9(1):143-150 (Pubitemid 44901880)
15. Kand'ar R, Zakova P (2009) Determination of 25-hydroxy-vitamin D3 in human plasma using HPLC with UV detection based on SPE sample preparation. J Sep Sci 32(17):2953-2957
16. Lu W et al (2002) Rapid method for the determination of total 5-methyltetrahydrofolate in blood by liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 766(2):331-337
17. Kabat GC, Rohan TE (2007) Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control 18(10):1047-1053 (Pubitemid 47498168)
18. Reizenstein P (1991) Iron, free radicals and cancer. Med Oncol Tumor Pharmacother 8(4):229-233
19. McCord JM (2004) Iron, free radicals, and oxidative injury. J Nutr 134(11):3171S-3172S
20. Stevens RG (2000) Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation. Radiat Res 154(6):725-726; discussion 726-727
21. Adzersen KH et al (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany. Nutr Cancer 46(2):131-137
22. Negri E et al (1996) Intake of selected micronutrients and the risk of breast cancer. Int J Cancer 65(2):140-144 (Pubitemid 26048911)
23. Levi F et al (2001) Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 91(2):260-263 (Pubitemid 32041750)
24. Kabat GC et al (2010) Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 92(6):1478-1483
25. Kabat GC et al (2007) Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 16(6):1306-1308 (Pubitemid 46984977)
26. Ferrucci LM et al (2009) Intake of meat, meat mutagens, and iron and the risk of breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer 101(1):178-184
27. Kallianpur AR et al (2008) Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat 107(1):123-132 (Pubitemid 350179598)
28. Ionescu JG et al (2006) Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 27(Suppl 1):36-39 (Pubitemid 46542114)
29. Cui Y et al (2007) Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev 16(8):1682-1685 (Pubitemid 47294838)
30. Huang YL, Sheu JY, Lin TH (1999) Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 32(2):131-136
31. Knekt P et al (1994) Body iron stores and risk of cancer. Int J Cancer 56(3):379-382 (Pubitemid 24087632)
32. Ulbrich EJ et al. (2003) Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res 23(6D):5107-5109 (Pubitemid 38182132)
33. Bae YJ et al (2009) Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients. J Clin Biochem Nutr 45(3):355-360
34. Wu T et al (2004) Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 14(3):195-201 (Pubitemid 38249333)
35. Pasha Q et al (2010) Comparison of trace elements in the scalp hair of malignant and benign breast lesions versus healthy women. Biol Trace Elem Res 134(2):160-173
36. Wang T et al (2009) Use of scalp hair as indicator of human exposure to heavy metals in an electronic waste recycling area. Environ Pollut 157(8-9):2445-2451
37. Pereira R, Ribeiro R, Goncalves F (2004) Scalp hair analysis as a tool in assessing human exposure to heavy metals (S. Domingos mine, Portugal). Sci Total Environ 327(1-3):81-92 (Pubitemid 38698309)
38. Jian J et al (2011) Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med 50(7):841-847
39. Huang X (2008) Does iron have a role in breast cancer? Lancet Oncol 9(8):803-807
40. Hayes RB (1997) The carcinogenicity of metals in humans. Cancer Causes Control 8(3):371-385
41. De Boeck M, Kirsch-Volders M, Lison D (2003) Cobalt and antimony: genotoxicity and carcinogenicity. Mutat Res 533(1-2):135-152 (Pubitemid 37487865)
42. McCallum RI (2005) Occupational exposure to antimony compounds. J Environ Monit 7(12):1245-1250
43. Benderli Cihan Y, Sozen S, Ozturk Yildirim S (2011) Trace elements and heavy metals in hair of stage III breast cancer patients. Biol Trace Elem Res 144(1-3):360-379
44. Choe SY et al (2003) Evaluation of estrogenicity of major heavy metals. Sci Total Environ 312(1-3):15-21
45. Groff JL, Gropper SS (eds) (1999) The fat-soluble vitamins. In Advanced nutrition and human metabolism. Peter Marshall, Belmont, CA, pp 316-331
46. Fairfield KM, Fletcher RH (2002) Vitamins for chronic disease prevention in adults: scientific review. JAMA 287(23):3116-3126 (Pubitemid 34633987)
47. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1(3):181-193 (Pubitemid 33741893)
48. Fulan H et al. (2011) Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes Control 22(10):1383-1396
49. Tamimi RM et al (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer.AmJ Epidemiol 161(2):153-160 (Pubitemid 40096790)
50. Epplein M et al (2009) Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study. Breast Cancer Res 11(4):R49
51. Welsh J et al (2002) Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83(1-5):85-92
52. Jensen SS et al (2001) Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 15(8):1370-1380 (Pubitemid 32703484)
53. Colston KW, Berger U, Coombes RC (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1(8631):188-191 (Pubitemid 19038805)
54. Colston KW et al (2003) Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors. Breast Cancer Res Treat 80(3):303-311 (Pubitemid 37046754)
55. Nolan E et al (1998) Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells. Mol Cell Biochem 188(1-2):13-20 (Pubitemid 28493313)
56. VanWeelden K et al (1998) Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology 139(4):2102-2110
57. Hollis BW (1996) Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 58(1):4-5
58. Eliassen AH et al (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 13(3):R50
59. Hiatt RA et al (1998) Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst 90(6):461-463 (Pubitemid 28160638)
60. Bertone-Johnson ER et al (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14(8):1991-1997 (Pubitemid 41161213)
61. Dorjgochoo T et al (2009) Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS). Breast Cancer Res Treat 117(2):381-389
62. Dorgan JF et al (1998) Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 9(1):89-97 (Pubitemid 28048664)
63. Sato R et al (2002) Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 11(5):451-457 (Pubitemid 34517940)
64. Navarro Silvera SA, Rohan TE (2007) Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18(1):7-27
65. Gupta SK et al (1991) Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 46(3):178-181
66. Huzarski T et al (2006) A lowering of breast and ovarian cancer risk in women with a BRCA1 mutation by selenium supplementation of diet. Hered Cancer Clin Pract 4(1):58
67. Hunter D (1998) Biochemical indicators of dietary intake. In: Willett W (ed) Nutritional epidemiology. Oxford Press, Oxford, p 174
68. Kim YI (2007) Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51(3):267-292
69. Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64-76
70. Lewis SJ et al (2006) Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 98(22):1607-1622 (Pubitemid 44811644)
71. Lin J et al (2008) Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 87(3):734-743 (Pubitemid 351364556)
72. Stolzenberg-Solomon RZ et al (2006) Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Clin Nutr 83(4):895-904 (Pubitemid 44713156)
73. Stevens VL et al (2010) Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the cancer prevention study II nutrition cohort. Am J Clin Nutr 91(6):1708-1715
74. Faulk WP, Hsi BL, Stevens PJ (1980) Transferrin and transferrin receptors in carcinoma of the breast. Lancet 2(8191):390-392
75. Rossiello R, Carriero MV, Giordano GG (1984) Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 37(1):51-55 (Pubitemid 14218063)
76. Hou MF et al (1998) Serum vitamin A level in breast cancer patients. Kaohsiung J Med Sci 14(11):673-678